Risk factors in established coronary heart disease: evaluation of a secondary prevention programme

T Kahan1, P Wändell

  • 1Division of Internal Medicine, Karolinska Institutet Danderyd Hospital, Danderyd, Sweden. thomas.kahan@med.ds.sll.se

Insights

Coronary heart disease patients often have modifiable risk factors, with few achieving lipid goals. Secondary prevention programs help, but further education is needed for better outcomes in managing heart disease.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality in developed nations.
  • Secondary prevention programs aim to manage CHD and its risk factors.
  • This study investigates patient compliance and gender-specific differences within a CHD secondary prevention program.

Purpose of the Study:

  • To assess the adherence and effectiveness of a secondary prevention program for coronary heart disease (CHD) patients.
  • To identify potential gender-based disparities in the management of CHD risk factors and treatment adherence.
  • To evaluate the achievement of therapeutic goals for various cardiovascular risk factors.

Main Methods:

  • A cross-sectional survey was conducted among 760 CHD patients (up to 75 years old).
  • Patients were recruited from hospital cardiology outpatient clinics and primary care centers.
  • Data were collected via questionnaires administered by cardiologists and primary care physicians.

Main Results:

  • Therapeutic goal achievement varied: 29-36% for cholesterol, 42-50% for triglycerides, 66-72% for blood glucose, 84-86% for blood pressure, and 16-20% for smoking cessation.
  • Hospital care patients were more likely to undergo echocardiography (OR 2.69).
  • Men received more echocardiograms (OR 2.59) and specific medications like ACE-inhibitors (OR 2.04) and beta-blockers (OR 1.82), while women were more often prescribed diuretics (OR 0.49).

Conclusions:

  • CHD patients exhibit a high prevalence of modifiable risk factors, with suboptimal control of lipid levels.
  • While secondary prevention programs are beneficial, enhanced educational strategies are necessary to improve patient outcomes.
  • Addressing gender-specific patterns in treatment and risk factor management is crucial for optimizing CHD care.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...